title: Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
authors.affiliation: La Jolla Institute for Molecular Medicine, San Diego, Calif., USA.
authors.forename: Daniela
authors.initials: D
authors.lastname: Virgintino
authors.forename: Ugur
authors.initials: U
authors.lastname: Ozerdem
authors.forename: Francesco
authors.initials: F
authors.lastname: Girolamo
authors.forename: Luisa
authors.initials: L
authors.lastname: Roncali
authors.forename: William B
authors.initials: WB
authors.lastname: Stallcup
authors.forename: Roberto
authors.initials: R
authors.lastname: Perris
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D042501:Angiogenic Proteins / Q000378:metabolism; D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D020286:Pericytes / Q000187:drug effects* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D020533:Angiogenesis Inhibitors; D042501:Angiogenic Proteins